Shares of Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) traded higher on Tuesday after Secretary of the U.S.

Illinois-based Abbott Laboratories required job applicants to disclose their family medical histories in violation of the state’s Genetic Information Privacy Act, a proposed federal class action said.

A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...

Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 5.3% over the past three months. Since the market usually pay for a company’s long-term financial health, we ...

Recent events for Abbott Laboratories (NYSE:ABT) include the integration of Beta Bionics' iLet Bionic Pancreas with Abbott's sensor technology and a partnership with the Department of Health - Abu ...

Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...